ROS Dynamics Controlled by Polyoxometalate-Functionalized Fe3O4 Nanozyme for Infected Wound Healing

A new inorganic “nanozyme” approach is aiming to improve treatment for infected wounds by solving a long-standing problem: how to use reactive oxygen species (ROS) to kill bacteria without damaging healthy tissue. Infected sites often become acidic, and ROS levels fluctuate as healing progresses—creating a moving target for therapy.

The study, published in Nano Research, reports a pH-responsive bifunctional catalyst built from Fe₃O₄ decorated with a sub-nanoscale cluster of 12-phosphotungstic acid (PTA). The design is intended to dynamically tune ROS behavior rather than simply increase ROS production, which can otherwise worsen oxidative injury.

Lead author Guolie Xiang and colleagues from Beijing University of Chemical Technology (BUCT) engineered the Fe₃O₄-PTA nanozyme to switch roles depending on local pH. In the acidic microenvironment typical of infected wounds, the catalyst behaves like a peroxidase, promoting hydrogen peroxide conversion into highly reactive ROS.

Those ROS species then attack bacterial membranes and drive bacterial death, delivering strong antibacterial effects when and where pathogens are most active. Importantly, the work does not treat ROS as a one-time weapon. It leverages the fact that wound conditions gradually return toward physiological pH during tissue repair.

As pH normalizes, the nanozyme transitions into a ROS-scavenging mode. In this later stage, it helps neutralize excess ROS and reduces oxidative stress, supporting healthier tissue remodeling. The same catalytic platform thus provides both bacterial eradication and protection of surrounding cells across different phases of healing.

To substantiate the mechanism, the researchers evaluated catalytic performance against common peroxidase-like substrates and performed antioxidant assays targeting multiple ROS types, including hydroxyl radicals and hydrogen peroxide. The data indicate efficient redox regulation consistent with the observed biological outcomes.

In vivo infected wound models further confirmed therapeutic benefits. Compared with Fe₃O₄ alone, the PTA-functionalized system accelerated wound closure, lowered inflammatory responses, and improved tissue structure restoration. These results highlight the role of sub-nanoscale polyoxometalate cluster engineering in controlling nanozyme reactivity.

The authors emphasize that rational design of inorganic catalysts can achieve “precise redox regulation” in complex biological environments. By integrating ROS generation and ROS removal into a single pH-responsive system, the platform may help reduce risks linked to ROS overproduction while maintaining antibacterial potency.

Overall, the work positions Fe₃O₄-PTA as a versatile strategy for ROS-related pathological conditions. Beyond wound therapy, the same design concept could be adapted to other inflammatory or tissue-repair scenarios where redox homeostasis determines outcomes.

Keywords

pH-responsive nanozyme; ROS dynamics; Fe₃O₄; phosphotungstic acid (PTA); infected wound healing; polyoxometalate clusters; peroxidase-like catalysis; bacterial eradication; oxidative stress control; redox homeostasis